Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Boron in nuclear medicine: New synthetic approaches to PET, SPECT and BNCT agents

Technical Report ·
DOI:https://doi.org/10.2172/6648872· OSTI ID:6648872
The primary objective of the Department of Energy (DOE) Nuclear Medicine Program at the University of Tennessee is the creation of new methods for introducing short-lived isotopes into agents for use in PET and SPECT. A small, but significant portion of our effort is directed toward the design of boron-containing neutron therapy agents. The uniqueness of the UT program is its focus on the design of new chemistry (molecular architecture) and technology as opposed to the application of know reactions to the synthesis of specific radiopharmaceuticals. The new technology is then utilized in nuclear medicine research at the UT Biomedical Imaging Center and in collaboration with colleagues at other DOE facilities (Brookhaven National Laboratory, Oak Ridge National Laboratory, Los Alamos National Laboratory, and Oak Ridge Associated Universities). An important goal of the DOE Nuclear Medicine Program at UT is to provide training for students (predoctoral and postdoctoral) in the scientific aspects of nuclear medicine. The academic nature of the program facilitates collaborative interactions with other DOE nuclear medicine programs and helps to insure the continued availability of skilled scientists dedicated to the advancement of nuclear medicine.
Research Organization:
Tennessee Univ., Knoxville, TN (USA). Dept. of Chemistry
Sponsoring Organization:
DOE/ER
DOE Contract Number:
FG05-86ER60434
OSTI ID:
6648872
Report Number(s):
DOE/ER/60434-5; ON: DE90017335
Country of Publication:
United States
Language:
English